Addressing resistance evolution in Pseudomonas aeruginosa using pharmacodynamic modelling: application to meropenem dosage and combination therapy

Multiple Mechanisms of Antimicrobial Resistance in Pseudomonas aeruginosa: Our Worst Nightmare?

D. M. Livermore · Clinical Infectious Diseases · 2002 · 1.4K citations

Life Sciences, Infectious Diseases, Microbiology +17

Of Pseudomonas, porins, pumps and carbapenems

David M. Livermore · Journal of Antimicrobial Chemotherapy · 2001 · 388 citations · Full text

Life Sciences, Infectious Diseases, Microbiology +9

Health and Economic Outcomes of Antibiotic Resistance in Pseudomonas aeruginosa

Yehuda Carmeli, Nicolas Troillet, Adolf W. Karchmer et al. · Archives of Internal Medicine · 1999 · 370 citations

Life Sciences, Microbiology, Pharmacoeconomics +17

Characterization of<i>Pseudomonas aeruginosa</i>Isolates: Occurrence Rates, Antimicrobial Susceptibility Patterns, and Molecular Typing in the Global SENTRY Antimicrobial Surveillance Program, 1997–1999

Ana Cristina Gales, Robert N. Jones, John Turnidge et al. · Clinical Infectious Diseases · 2001 · 311 citations

Veterinary Medicine, Infectious Diseases, Microbiology +17

Optimization of Meropenem Minimum Concentration/MIC Ratio To Suppress In Vitro Resistance of <i>Pseudomonas aeruginosa</i>

Vincent H. Tam, Amy N. Schilling, Shádi Neshat et al. · Antimicrobial Agents and Chemotherapy · 2005 · 196 citations · Full text

Life Sciences, Microbiology, Pharmacology +16